Amrize Ltd $AMRZ Shares Sold by J. Safra Sarasin Holding AG

J. Safra Sarasin Holding AG lessened its position in shares of Amrize Ltd (NYSE:AMRZ) by 10.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 101,026 shares of the company’s stock after selling 11,224 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Amrize were worth $5,474,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in AMRZ. MCF Advisors LLC acquired a new stake in shares of Amrize during the 4th quarter worth about $27,000. Basepoint Wealth LLC purchased a new position in shares of Amrize during the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC purchased a new stake in Amrize in the fourth quarter valued at approximately $34,000. US Bancorp DE acquired a new position in Amrize during the third quarter worth $38,000. Finally, Itau Unibanco Holding S.A. grew its stake in shares of Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after buying an additional 450 shares in the last quarter.

Insider Buying and Selling

In related news, CTO Roald Brouwer acquired 1,500 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were acquired at an average cost of $49.84 per share, for a total transaction of $74,760.00. Following the acquisition, the chief technology officer directly owned 19,757 shares in the company, valued at approximately $984,688.88. The trade was a 8.22% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Jan Philipp Jenisch purchased 3,000 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average cost of $49.96 per share, for a total transaction of $149,880.00. Following the purchase, the chief executive officer owned 515,000 shares of the company’s stock, valued at $25,729,400. This trade represents a 0.59% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 54,920 shares of company stock worth $2,717,429 in the last ninety days. 0.54% of the stock is currently owned by insiders.

Amrize Stock Performance

NYSE AMRZ opened at $49.08 on Tuesday. The stock has a market capitalization of $27.15 billion and a price-to-earnings ratio of 23.48. The business’s 50 day moving average is $52.56 and its two-hundred day moving average is $55.46. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $65.94. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38.

Amrize (NYSE:AMRZ) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company’s quarterly revenue was up 4.7% on a year-over-year basis. Research analysts expect that Amrize Ltd will post 2.74 EPS for the current year.

Amrize Cuts Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is currently 21.05%.

Wall Street Analysts Forecast Growth

AMRZ has been the subject of several recent research reports. Sanford C. Bernstein reissued an “outperform” rating on shares of Amrize in a research note on Monday, June 22nd. Weiss Ratings downgraded Amrize from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, May 18th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Truist Financial reaffirmed a “hold” rating and issued a $48.00 target price (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. Finally, Stephens restated an “overweight” rating and issued a $65.00 price objective on shares of Amrize in a report on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Amrize has a consensus rating of “Moderate Buy” and an average target price of $63.00.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.